Journals / Respiratory Case Reports / 2021 / Cilt: 10 - Sayı: 1

Thrombocytopenia as First Manifestation of Acute Massive Pulmonary Embolism

Akut Masif Pulmoner Embolinin İlk Belirtisi Olarak Trombositopeni

Pages
36–40
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Clinicians should remain vigilant to ensure early diagnosis and improved outcomes.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Massive acute pulmonary embolism (PE) is a lifethreatening medical condition.
📊
Key Findings & Data:A 64-year-old female was admitted for left femur osteomyelitis with a sub-periosteal abscess that was causing pain and immobility.
💡
Conclusion & Impact:Clinicians should remain vigilant to ensure early diagnosis and improved outcomes.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Massive acute pulmonary embolism (PE) is a lifethreatening medical condition. Occasionally, patients experiencing a massive PE may develop concurrent thrombocytopenia. A 64-year-old female was admitted for left femur osteomyelitis with a sub-periosteal abscess that was causing pain and immobility. There were no indications suggesting underlying thrombophilia or malignancy. On day 5 of admission, the patient developed acute onset respiratory distress, necessitating intubation and vasopressor support. A computed tomography pulmonary angiogram revealed a massive PE involving the left main trunk and left ascending pulmonary artery. The patient had experienced an unexplained worsening thrombocytopenia that despite without heparin use previously. There was clear indication for thrombolysis, but the treatment was contraindicated. After a multidisciplinary meeting it was decided to optimize platelet counts prior to the performance of a surgical embolectomy, however the patient succumbed 2 days later. The unexplained thrombocytopenia could be the only clue for massive PE. Clinicians should remain vigilant to ensure early diagnosis and improved outcomes.

Özet

Masif pulmoner emboli (PE) hayatı tehdit eden medikal bir durumdur. Bazen, masif PE geçiren hastalarda, eşlik eden bir trombositopeni görülebilir. Sol femurda ağrı ve hareket kısıtlığına neden olan subperiostal apseli osteomiyeliti bulunan 64 yaşındaki kadın hasta yatırıldı. Altta yatan trombofili veya maligniteyi düşündüren bir bulgusu yoktu. Yatışın beşinci gününde, vasopresör desteği ve entübasyon gerektiren akut bir solunum sıkıntısı ortaya çıktı. Pulmoner tomografik angiografide, sol inen pulmoner arter ve sol ana pulmoner arterde masif bir pulmoner emboli görüldü. Öncesinde heparin kullanmamasına rağmen açıklanamayan trombositopeni gelişti. Trombolitik tedavi ihtiyacı olmasına rağmen, bu tedavi kont- rendike idi. Multidisipliner bir toplantıda cerrahi embolektomi öncesi trombosit sayısını düzeltme kararı alındı. Ancak hasta iki gün içinde kaybedildi. Açıklanamayan bir trombositopeni masif PE için tek ipucu olabilir. Klinisyenlerin, erken tanı ve daha iyi sonuçlar elde etmeleri için dikkatli olmaları gerekir.

🔖

Cite This Article

HUAN, N., NG, K. Y., NG, K. L., RAHAMAN, J. A. A. (2022). Thrombocytopenia as First Manifestation of Acute Massive Pulmonary Embolism. Respiratory Case Reports, Cilt: 10 - Sayı: 1, 36–40. https://ajindex.com/articles/588880

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Torbicki A, van Beek EJR, Charbonnier B, Meyer G, Mor- purgo M, Palla A, et al. Guidelines on diagnosis and management of acute pulmonary embolism. Task Force on Pulmonary Embolism - European Society of Cardio- logy. Eur Heart J 2000; 21:1301-36. [CrossRef] 2. Kasper W, Konstantinides S, Geibel A, Olschewski M, Heinrich F, Grosser KD, et al. Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol 1997; 30:1165-71. [CrossRef] 3. Munoz Tovar RA, Alvares Perdomo LC, Rojas Molina SM, Salazar SJ. Submassive pulmonary thromboembolism in a patient with thrombocytopenia: Therapeutic challenge. Case Rep Crit Care 2019; Article ID 1919401. [CrossRef] 4. Kitchens CS. Thrombocytopenia due to acute venous thromboembolism and its role in expanding the differen- tial diagnosis of heparin-induced thrombocytopenia. Am J Hematol 2004; 76: 69-73. [CrossRef] 5. Aggarwal V, Nicolais CD, Lee A, Bashir R. Acute mana- gement of pulmonary embolism. American College of Cardiology. https://www.acc.org/. Oct 2017. 6. Lim MS, Enjeti AK. Safety of anticoagulation in the treat- ment of venous thromboembolism in patients with hae- matological malignancies and thrombocytopenia: Report of 5 cases and literature review. Crit Rev Oncol Hematol 2016; 105:92-9. [CrossRef] 7. Warkentin TE. Heparin-induced thrombocytopenia. In: Kitchens, CS, Alving BM, Kessler CM, eds. Consultative hemostasis and thrombosis. Philadelphia: W.B. Saunders; 2002: 355-372. 8. Mavrommatis AC, Theodoridis T, Orfanidou A, Roussos C, Christopoulou-Kokkinou V, Zakynthinos S. Coagula- tion system and platelets are fully activated in uncompli- cated sepsis. Crit Care Med 2000; 28:451-7. [CrossRef] 9. Ghosh TK, Khan N, Malik A. Platelet auto-antibodies in septicaemic patients. Indian J Pathol Microbiol 1999; 42:31-5. 10. François B, Trimoreau F, Vignon P, Fixe P, Praloran V, Gastinne H: Thrombocytopenia in the sepsis syndrome: role of hemophagocytosis and macrophage colony- stimulating factor. Am J Med 1997; 103:114-20. [CrossRef] 11. Stephan F, Thioliere B, Verdy E, Tulliez M. Role of he- mophagocytic histiocytosis in the etiology of thrombocy- topenia in patients with sepsis syndrome or septic shock. Clin Infect Dis 1997; 25:1159-64. [CrossRef] 12. Venkata C, Kashyap R, Farmer JC, Afessa B. Thrombocy- topenia in adult patients with sepsis: incidence, risk fac- tors, and its association with clinical outcome. J Intensive Care 2013; 1: 9. [C